<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-24T22:50:52Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/380888" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/380888</identifier><datestamp>2025-03-04T01:43:01Z</datestamp><setSpec>com_1810_307305</setSpec><setSpec>com_1810_256062</setSpec><setSpec>col_1810_346969</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Investigating coordination between stress-induced  translational and transcriptional attenuation</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.116326</dc:identifier>
   <dc:creator>Singh, Oski</dc:creator>
   <uketdterms:advisor>Sawarkar, Ritwick</uketdterms:advisor>
   <dcterms:abstract>Neurodegeneration represents a significant health problem worldwide. Protein misfolding, 
mitochondrial dysfunction, and oxidative stress are all common features of 
neurodegeneration. To date, there is little therapeutic intervention available to tackle 
neurodegenerative disease.  
Protein misfolding results in the activation of several stress-induced processes including the 
integrated stress response (ISR) and stress-induced transcriptional downregulation (SITA). 
SITA and the ISR inhibit global transcription and translation respectively, while stress-induced 
transcripts escape both pathways and are upregulated. The ISR is physiologically relevant in 
neurodegenerative disease. Activation of the ISR is typified by phosphorylation of the α 
subunit on the eukaryotic initiation factor 2 (eIF2α), phospho-eIF2α (P-eIF2α) has been 
detected in a wide range of neurodegenerative disorders including Alzheimer’s disease, 
Parkinson’s disease and Huntington disease. SITA has also been evidenced in a Huntington’s 
disease model although little is known about the physiological relevance of SITA.  
Evidence of ISR activity in neurodegenerative disease models resulted in the production of a 
small molecule inhibitor of the ISR, ISR inhibitor (ISRIB). ISRIB treatment has been shown to 
improve age-related cognitive decline in mice. ISRIB treatment is also neuroprotective in prion
diseased mice. Although ISRIB has not been shown as a human therapeutic, the use of ISRIB 
in mouse models exemplifies the importance of the ISR in neurodegenerative disease and 
brain activity. In this thesis, we consider the importance of both SITA and the ISR in 
neurodegenerative disorders and potential therapeutic intervention to inhibit both stress
induced pathways in an effort to limit the disease-associated downregulation of gene 
expression. We also explore the relationship between ISR and SITA activation to elicit a 
coordinated pro-survival response. 
Results from this thesis show that SITA is inhibited by overexpression of the cyclin in the 
positive transcription elongation factor b (P-TEFb) complex, cyclin T1 (CCNT1), during acute 
heat shock (HS) and oxidative stress in cellulo. In identical conditions, CCNT1 overexpression 
has been shown to regulate the rate of ISR recovery. Multiple mechanisms of action have 
been suggested for further research; CCNT1 may interact with the ISR-induced activating 
transcription factor 4 (ATF4) and enhance transcription of genes that produce proteins 
involved in dephosphorylation of eIF2α or CCNT1 may directly interfere with ISR activation 
mechanisms. 
The translational impact of CCNT1 overexpression was also considered in basal, stress-free, 
conditions. Surprisingly, CCNT1 overexpression resulted in translational attenuation and ISR 
3 
activation in a cell cycle specific manner. A subset of G1 cells overexpressing CCNT1 show 
ISR activation. Although cell cycling has not been previously linked to the P-TEFb, the P-TEFb 
is required for the transcription of early G1 genes, facilitating the M/G1 transition in the cell 
cycle. Multiple hypotheses were suggested for further research based on this data, CCNT1 
overexpression may increase cell proliferation and the rate of mitosis causing proteotoxic 
stress and ISR activation in daughter cells. Both overactivity of the P-TEFb and ISR activation 
are associated with therapy-resistant cancers, therefore these results may allude to 
understanding how the ISR becomes activated in cancers that present raised P-TEFb activity. 
Since CCNT1 overexpression is considered as a therapeutic intervention in this thesis, the 
impact of CCNT1 on the cell cycle and translation in the absence of stress must be considered 
when utilizing CCNT1 as a therapeutic. 
The mechanistic data in this study has been based on acute stress responses (1 hour of 
treatment with stressful stimuli). In neurodegenerative disease, the ISR is chronically 
activated. We therefore tested multiple neurodegenerative disease models for SITA activation. 
SITA was identified in a microglial cell line however could not be shown in primary murine 
brain mix culture, further research will identify stress response pathways in specific brain cell 
types to identify which cells in the brain react to stress by inhibiting transcription.  
Overall, this project shows the role of CCNT1 overexpression in SITA and the ISR during acute 
stress and shows the potential for manipulation of the P-TEFb to be used as a therapeutic in 
the context of neurodegenerative disease.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2024-09-28</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/380888</dcterms:isReferencedBy>
   <uketdterms:embargotype>embargo</uketdterms:embargotype>
   <uketdterms:embargodate>2026-03-03</uketdterms:embargodate>
   <dc:identifier xsi:type="dcterms:URI">https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/62301d98-15e3-4b35-acb3-a05100df3803/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">bb47dec1bd02e5e05ca802b9623c7baf</uketdterms:checksum>
   <dcterms:license>https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/19f50dea-0554-41f9-9093-a5aed27f5fc4/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>http://purl.org/NET/rdflicense/allrightsreserved</dc:rights>
   <dc:subject>CyclinT1</dc:subject>
   <dc:subject>Neurodegeneration</dc:subject>
   <dc:subject>Transcription</dc:subject>
   <dc:subject>Translation</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>